(Q61136608)

2

0 references

Yoshiaki Kassai

3

0 references

Masaru Takeshita

4

0 references

Atsuko Murota

5

0 references

Yasushi Kondo

6

0 references

Tatsuya Ando

7

0 references

Yusuke Nakayama

8

0 references

Yuumi Okuzono

9

0 references

Maiko Takiguchi

10

0 references

Rina Kurisu

11

0 references

Takahiro Miyazaki

12

0 references

Keiko Yoshimoto

13

0 references

Hidekata Yasuoka

14

0 references

Kunihiro Yamaoka

15

0 references

Rimpei Morita

16

0 references

Akihiko Yoshimura

17

0 references

Hiroyoshi Toyoshiba

18

0 references

Tsutomu Takeuchi

Creative Commons Attribution 4.0 International

19

0 references

language of work or name

English

0 references

publication date

16 July 2018

0 references

published in

Nature Communications

0 references

volume

9

0 references

issue

1

0 references

page(s)

2755

0 references

copyright license

start time

16 July 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

describes a project that uses

limma

1 reference

Europe PubMed Central

22 June 2022

https://europepmc.org/article/PMC/6048065

inferred from PubMed Central ID database lookup

cites work

The pathogenesis of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: disassociation of the link between inflammation and destruction

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspective

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now?

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Remission in rheumatoid arthritis: is it all the same?

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Modular analysis of peripheral blood gene expression in rheumatoid arthritis captures reproducible gene expression changes in tumor necrosis factor responders

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapy

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Social network architecture of human immune cells unveiled by quantitative proteomics

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Leukocytosis in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Serum proteomic analysis identifies interleukin 16 as a biomarker for clinical response during early treatment of rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

C-reactive protein in rheumatology: biology and genetics

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

The Molecular Signatures Database (MSigDB) hallmark gene set collection

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

The complement system as a potential therapeutic target in rheumatic disease.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

The Disease Activity Score and the EULAR response criteria

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Monocyte alterations in rheumatoid arthritis are dominated by preterm release from bone marrow and prominent triggering in the joint

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Gene expression analysis of peripheral cells for subclassification of pediatric inflammatory bowel disease in remission

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Leukocytosis in obese individuals: possible link in patients with unexplained persistent neutrophilia

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Monocytosis and a Low Lymphocyte to Monocyte Ratio Are Effective Biomarkers of Ulcerative Colitis Disease Activity

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Obesity reduces the drug survival of second line biological drugs following a first TNF-α inhibitor in rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

A simplified disease activity index for rheumatoid arthritis for use in clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Adjusting batch effects in microarray expression data using empirical Bayes methods

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Identification of definitive serum biomarkers associated with disease activity in primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Standardizing immunophenotyping for the Human Immunology Project

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Capturing heterogeneity in gene expression studies by surrogate variable analysis

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

limma powers differential expression analyses for RNA-sequencing and microarray studies

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Development of a Drug-Response Modeling Framework to Identify Cell Line Derived Translational Biomarkers That Can Predict Treatment Outcome to Erlotinib or Sorafenib

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Enrichment map: a network-based method for gene-set enrichment visualization and interpretation

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

GSVA: gene set variation analysis for microarray and RNA-seq data.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Ontology-Based Meta-Analysis of Global Collections of High-Throughput Public Data

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-05044-4

7 January 2021

Body mass index and response to infliximab in rheumatoid arthritis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30013029

12 December 2020

inferred from PubMed ID database lookup

How obesity affects the neutrophil/lymphocyte and platelet/lymphocyte ratio, systemic immune-inflammatory index and platelet indices: a retrospective study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30013029

12 December 2020

inferred from PubMed ID database lookup

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30013029

12 December 2020